Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors

CARLSBAD, Calif., Nov. 4 /PRNewswire/ -- GenVault Corporation (Carlsbad, CA) today announces that William Brody, M.D., Ph.D., has joined its Board of Directors. Dr. Brody, the Irwin Jacobs Presidential Chair of the Salk Institute, is an acclaimed physician-scientist and university leader. Prior to joining the Salk Institute, Dr. Brody served as president of The Johns Hopkins University. He is a member of the National Academy of Engineering and the Institute of Medicine, and is renowned for his academic achievements and his contributions to the field of biomedical engineering. Further, Dr. Brody co-founded three medical device companies and holds two U.S. patents in the field of medical imaging.

"We are all excited to welcome Dr. Brody to our Board of Directors and are extremely privileged to work with such a high caliber and accomplished individual," said Dr. David Wellis, President and CEO of GenVault Corporation. "The impressive depth of academic, engineering and medical experience and national and international credibility that Dr. Brody brings with him will be key in guiding our strategic focus as GenVault continues its expansion from biobanking into the genomic transport and analysis markets," continued Dr. Wellis.

Dr. Brody commented, "In this era of explosive growth for genomic analysis and genetic testing, the number of DNA and RNA samples stored, transported and analyzed is increasing exponentially. GenVault's products and technologies help researchers keep pace with this increase and also reduce the cost, complexity and waste associated with existing sample management methods. I look forward to working with GenVault as we develop and bring to market further innovative and sustainable sample management solutions for the life science and clinical marketplaces," said Dr. Brody.

Dr. Brody received his B.S. and M.S. degrees in electrical engineering from the Massachusetts Institute of Technology. He received his Ph.D. (also in electrical engineering) and his M.D. degrees from Stanford University.

Dr. Brody currently serves on a number of national boards, including IBM, Stanford University, and Novartis. He is a member of the Scientific Management Review Board of the National Institutes of Health. Dr. Brody has also been a national figure in efforts to encourage innovation and strengthen the U.S. economy through investments in research and education.

About GenVault
GenVault is the global leader in providing risk free biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable, reliable and environmentally friendly alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlates to the Dynamic Archive, GenVault is continuously developing and refining best practices for biosample management and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
David Wellis
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91851

    CONTACT:
    David Wellis
    President & CEO
    (760) 268-5256
    dwellis@genvault.com